Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils

R. K. Thimmulappa, R. J. Fuchs, D. Malhotra, C. Scollick, K. Traore, J. H. Bream, M. A. Trush, K. T. Liby, M. B. Sporn, T. W. Kensler, S. Biswal

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalAntioxidants & Redox Signaling
Volume11
StatePublished - Nov 9 2007

Disciplines

  • Medicine and Health Sciences

Cite this